SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (1658)11/10/1998 11:22:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
Rudy,

60 cents is reasonable? If that is the case why didn't CIST sell immediately after the IMNX settlement 2 years ago for cash value?

Now we know the answer to that one don't we....



To: Rudy Saucillo who wrote (1658)11/10/1998 11:29:00 PM
From: Steve Harmon  Respond to of 2742
 
Cistron's shareholder meeting should be very interesting this year...



To: Rudy Saucillo who wrote (1658)11/11/1998 1:31:00 PM
From: Dr. John M. de Castro  Read Replies (1) | Respond to of 2742
 
Rudy, Does anyone want to venture a guess as to what Genome Securities will be doing for CIST? The PMC deal wrapped up the major marketable item in the company. So what is GS doing?

1) Selling the company
2) Draining Assets
3) Looking for a company to acquire

John de C


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News